Are typical starting doses of the selective serotonin reuptake inhibitors sub-optimal? A meta-analysis of randomized, double-blind, placebo-controlled, dose-finding studies in major depressive disorder.

Are typical starting doses of the selective serotonin reuptake inhibitors sub-optimal? A meta-analysis of randomized, double-blind, placebo-controlled, dose-finding studies in major depressive disorder.

Item
http://www.wikidata.org/entity/Q34617592
Quetiapine monotherapy in acute phase for major depressive disorder: a meta-analysis of randomized, placebo-controlled trialsEfficacy, tolerability, and acceptability of bupropion for major depressive disorder: a meta-analysis of randomized-controlled trials comparison with venlafaxineEfficacy, safety and tolerability of escitalopram in doses up to 50 mg in Major Depressive Disorder (MDD): an open-label, pilot study.Studies of long-term use of antidepressants: how should the data from them be interpreted?Strategic use of new generation antidepressants for depression: SUN(^_^)D study protocol.Pharmacological and combined interventions for the acute depressive episode: focus on efficacy and tolerabilityHow much to worry about the FDA warning in the use of citalopram?Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines.A mega-analysis of fixed-dose trials reveals dose-dependency and a rapid onset of action for the antidepressant effect of three selective serotonin reuptake inhibitors.An improved dosage regimen of sertraline hydrochloride in the treatment for premature ejaculation: an 8-week, single-blind, randomized controlled study followed by a 4-week, open-label extension study.Two Phase III randomised double-blind studies of fixed-dose TC-5214 (dexmecamylamine) adjunct to ongoing antidepressant therapy in patients with major depressive disorder and an inadequate response to prior antidepressant therapy.Serotoninergic effects on judgments and social learning of trustworthiness.CYP2D6 ultrarapid metabolism and early dropout from fluoxetine or amitriptyline monotherapy treatment in major depressive patients.A model to incorporate genetic testing (5-HTTLPR) in pharmacological treatment of major depressive disorders.
P2860

Are typical starting doses of the selective serotonin reuptake inhibitors sub-optimal? A meta-analysis of randomized, double-blind, placebo-controlled, dose-finding studies in major depressive disorder.

Item
http://www.wikidata.org/entity/Q34617592
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Are typical starting doses of ...... in major depressive disorder.
@ast
Are typical starting doses of ...... in major depressive disorder.
@en
Are typical starting doses of ...... in major depressive disorder.
@nl
type
label
Are typical starting doses of ...... in major depressive disorder.
@ast
Are typical starting doses of ...... in major depressive disorder.
@en
Are typical starting doses of ...... in major depressive disorder.
@nl
prefLabel
Are typical starting doses of ...... in major depressive disorder.
@ast
Are typical starting doses of ...... in major depressive disorder.
@en
Are typical starting doses of ...... in major depressive disorder.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Are typical starting doses of ...... in major depressive disorder.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921